QUECTEL-WIRELESS
25.7.2024 11:22:35 CEST | Business Wire | Press release
Quectel Wireless Solutions, a global IoT solutions provider, is pleased to announce the LG290P, the first quad-band GNSS module, designed to deliver high performance for the most demanding applications, ensuring exceptional RTK availability and quality even in challenging environments. Providing the instantaneous centimeter-level accuracy needed to ensure the precision required for applications such as precision agriculture, robotic lawn mowers, surveying and personal robots, the module also delivers superior coverage that supports base stations from greater distances, ensuring reliable performance.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240725061807/en/
Quectel unveils industry-first quad-band GNSS module, expanding comprehensive GNSS solutions portfolio (Photo: Business Wire)
The introduction of the LG290P module expands Quectel's range of high-accuracy, RTK-capable GNSS modules. This range includes the dual-band industrial-grade LC29H, the automotive-grade LG69T, and now the quad-band LG290P, providing users with a selection of GNSS modules to cover a wide variety of applications.
Future-proofing applications by supporting all constellations including GPS, GLONASS, Galileo, BDS, NavIC, QZSS, as well as SBAS support (WASS, EGNOS, MSAS, and GAGAN) and advanced satellite-based signals such as PPP-B2b, CLAS (QZSS L6), Galileo HAS E6, the LG290P is a cost-effective industrial-grade module that receives L1, L2, L5 and E6 frequency bands.
In addition, the LG290P is compatible with Quectel triple band RTK Services and ensures superior coverage that supports base stations from greater distances, ensuring stable and reliable performance in the most difficult urban environments, making it exceptionally well suited for sectors such as autonomous lawnmowers, delivery robots, surveying and precision agriculture. The quad-band solution can enhance the RTK fix rate by 50% compared to dual band in extremely challenging environments, such as a garden encircled by trees and walls. Additionally, it can reduce the time to achieve RTK fix to less than five seconds, in contrast to the ten to fifteen seconds required by the dual band solution.
“Introducing the quad-band GNSS Module to the market represents our commitment to advancing technology and providing our customers with the most reliable and accurate navigation solutions available,” said Norbert Muhrer, President and CSO, Quectel Wireless Solutions. “We believe this product will be a game-changer in many fields, enabling new possibilities and improving efficiencies and precise location.”
The module supports an advanced multi-frequency RTK algorithm, ensuring rapid and reliable RTK high-precision positioning results even in challenging conditions such as under dense tree cover, alongside buildings or inside urban canyons. With advanced anti-interference technology, the LG290P incorporates a professional-grade interference signal detection and Narrowband Interference Canceller (NIC), significantly enhancing signal reception performance in complex electromagnetic environments. Moreover, supporting integrity monitoring and authentication information verification, the LG290P aids automatic navigation systems in making control decisions, particularly fitting for critical applications like autonomous vehicles and lawnmowers.
The LG290P excels in terms of security by incorporating on-chip ECC check and Secure Boot for firmware protection. Measuring a compact 12.2 mm × 16.0 mm × 2.6 mm, the LG290P is the smallest quad-band module available, offering greater design flexibility for customers, reducing integration challenges, and enabling compact designs for a wide array of precision products.
Customers are also able to streamline their design process by sourcing the appropriate antenna for this module, ensuring flexibility and compatibility for diverse project requirements.
The LG290P quad band GNSS module is now available to order through the Quectel website and distributors.
About Quectel
Quectel’s passion for a smarter world drives us to accelerate IoT innovation. A highly customer-centric organization, we are a global IoT solutions provider backed by outstanding support and services. Our growing global team of 5,600 professionals sets the pace for innovation in cellular, GNSS, Wi-Fi and Bluetooth modules as well as antennas and services.
With regional offices and support across the globe, our international leadership is devoted to advancing IoT and helping build a smarter world.
For more information, please visit: www.quectel.com, LinkedIn, Facebook, and X.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240725061807/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press release
Potential first-in-class GPC3 x 4-1BB bispecific achieves a 36% confirmed response rate at Phase 3 dose and favorable safety profile in heavily pretreated liver cancerBrain-penetrant PRMT5 inhibitor shows promising antitumor and CNS activity in the largest publicly shared MTAP-deficient datasetFirst clinical data of CEA-targeting ADC demonstrates encouraging and sustained responses in CEAhigh NSCLC BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to dise
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press release
- Vertex is on track for the U.S. FDA Prescription Drug User Fee Act (PDUFA) date of November 30 for potential accelerated approval of povetacicept –- Data published in NEJM and presented at ASN highlight povetacicept’s unique trifecta of efficacy, favorable safety, and the simplicity of dosing at-home every 4 weeks with a low-volume autoinjector –- Data presented at ASN include a qualitative study examining patient perspectives on current and emerging IgAN therapies, showing that 96% of participants preferred an autoinjector over a prefilled syringe, and 80% of participants preferred dosing every 4 weeks versus weekly dosing - - New clinical studies of povetacicept underway including a study evaluating patient experience on povetacicept administered via autoinjector - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Soc
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press release
New data from HERIZON-GEA-01 Phase 3 trial show 36-month overall survival of nearly 40% with TEVIMBRA plus ZIIHERA and chemotherapy, and median OS reaching 27 monthsTEVIMBRA-containing arm was associated with a four-month longer median OS compared with ZIIHERA plus chemotherapy BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne,
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:10:00 CEST | Press release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press release
Collaboration will establish the roadmap for bringing Pony.ai robotaxis to Kazakhstan on the inDrive ride-hailing platform, leveraging the NVIDIA Hyperion and the NVIDIA Halos safety system. inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a lea
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
